Restricted accessReview articleFirst published online 2025
See it sooner: The role of point-of-care ultrasound in detecting malignant and invasive lesions presenting to the paediatric emergency department – A pictorial review
Undifferentiated paediatric patients can be difficult to correctly classify with the correct condition. This may be, in part, due to the unique differences in how symptoms present as well as the challenges clinicians face in undertaking a complete examination where cooperation may be hindered due to pain, anxiety or limited understanding. Point-of-care ultrasound is now recognised as a valuable tool to assist acute paediatricians in their decision-making and diagnosis when incorporated into their clinical assessment.
Conclusion:
We describe six cases which presented to the Paediatric Emergency Department, where point-of-care ultrasound played a crucial role in uncovering malignant or invasive lesions and subsequently expedited further investigations, leading to much quicker diagnosis.
MarshallTLRinkeMLOlsonAPJ, et al. Diagnostic error in pediatrics: a narrative review. Pediatrics2022; 149: e2020045948D.
2.
RolandDSnelsonE.‘So why didn’t you think this baby was ill?’ Decision-making in acute paediatrics. Arch Dis Child Educ Pract Ed2019; 104(1): 43–48.
3.
ScarramalJPLSlawkaESchmittL, et al. Diagnostic accuracy of ultrasonographic optic nerve sheath diameter compared to invasive ICP monitoring for intracranial hypertension in pediatric patients. Pediatr Radiol2025; 55: 1669–1681.
4.
AlexandridisGVerschuurenEWRosendaalAV, et al. Evidence base for point-of-care ultrasound (POCUS) for diagnosis of skull fractures in children: a systematic review and meta-analysis. Emerg Med J2022; 39: 30–36.
Gloeckler RiesLSmithMGurneyJ, et al. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program. Bethesda, MD: National Cancer Institute, 1999.
7.
ThienHHKim HoaNTDuyPC, et al. Pediatric primary orbital rhabdomyosarcoma. J Pediatr Surg Case Rep2020; 59: 101475.
8.
AmerKMThomsonJECongiustaD, et al. Epidemiology, incidence, and survival of rhabdomyosarcoma subtypes: SEER and ICES database analysis. J Orthop Res2019; 37: 2226–2230.
9.
KodetRNewtonWAHamoudiAB, et al. Orbital rhabdomyosarcomas and related tumors in childhood: relationship of morphology to prognosis–an Intergroup Rhabdomyosarcoma study. Med Pediatr Oncol1997; 29: 51–60.
10.
ShieldsJAShieldsCL.Rhabdomyosarcoma: review for the ophthalmologist. Surv Ophthalmol2003; 48: 39–57.
11.
KarciogluZAHadjistilianouDRozansM, et al. Orbital rhabdomyosarcoma. Cancer Control2004; 11: 328–333.
ShambergerRCAndersonJRBreslowNE, et al. Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5. Ann Surg2010; 251: 555–558.
14.
PaterLMelchiorPRübeC, et al. Wilms tumor. Pediatr Blood Cancer2021; 68: e28257.
van den Heuvel-EibrinkMM. Wilms tumor. Brisbane, QLD, Australia: Codon Publications, 2016.
17.
NarodSAHawkinsMMRobertsonCM, et al. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet1997; 60: 474–485.
18.
ForlenzaCJChadburnAGiulino-RothL.Primary mediastinal B-cell lymphoma in children and young adults. J Natl Compr Cancer Netw2023; 21: 323–330.
19.
A clinical evaluation of the international lymphoma study group classification of non-Hodgkin’s lymphoma. Blood1997; 89: 3909–3918.
20.
AhmedZAfridiSSShahidZ, et al. Primary mediastinal B-cell lymphoma: a 2021 update on genetics, diagnosis, and novel therapeutics. Clin Lymphoma Myeloma Leuk2021; 21: e865–e875.
21.
KyriakidisIPelagiadisIStratigakiM, et al. B–NHL cases in a tertiary pediatric hematology–oncology department: a 20-year retrospective cohort study. Life2024; 14: 633.
22.
SavageKJAl-RajhiNVossN, et al. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Ann Oncol2006; 17: 123–130.
23.
DourtheMEAuperinARigaudC, et al. Excellent outcome of children/adolescents with primary mediastinal large B-cell lymphoma treated with FAB/LMB-based chemotherapy regimen with rituximab. Haematologica2024; 109: 3790–3794.
24.
LiuHStillerCACrooksCJ, et al. Incidence, prevalence and survival in patients with Langerhans cell histiocytosis: a national registry study from England, 2013-2019. Br J Haematol2022; 199: 728–738.
25.
GulatiNAllenCE.Langerhans cell histiocytosis: version 2021. Hematol Oncol2021; 39: 15–23.
AlstonRDTatevossianRGMcNallyRJQ, et al. Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998. Pediatr Blood Cancer2007; 48: 555–560.
28.
GadnerHMinkovMGroisN, et al. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood2013; 121: 5006–5014.
29.
LoizosASoteriadesESPieridouD, et al. Lymphadenitis by non-tuberculous mycobacteria in children. Pediatr Int2018; 60: 1062–1067.
30.
MeoliADeolmiMIannarellaR, et al. Non-tuberculous mycobacterial diseases in children. Pathogens2020; 9: 553.
31.
LindeboomJASmetsAMJBKuijperEJ, et al. The sonographic characteristics of nontuberculous mycobacterial cervicofacial lymphadenitis in children. Pediatr Radiol2006; 36: 1063–1067.
32.
RoyCFBalakrishnanKBoudewynsA, et al. International pediatric otolaryngology group: consensus guidelines on the diagnosis and management of non-tuberculous mycobacterial cervicofacial lymphadenitis. Int J Pediatr Otorhinolaryngol2023; 166: 111469–111469.
33.
TabarestaniTQLevineNSachsE, et al. Giant cell tumor of bone in the pediatric population: a retrospective study highlighting cases of metaphyseal only location and increased local recurrence rates in skeletally immature patients. Skeletal Radiol2023; 52: 2399–2408.
34.
FedermanNBrienEWNarasimhanV, et al. Giant cell tumor of bone in childhood: clinical aspects and novel therapeutic targets. Paediatr Drugs2013; 16: 21–28.
35.
ÖzyükselGArdıçlıBÖzcanHN, et al. Giant cell tumor arising from the anterior arc of the rib: an extremely rare site in an adolescent girl. Turk J Pediatr2022; 64: 940–945.
36.
Schutte HenriETaconis WybrenK. Giant cell tumor in children and adolescents. Skeletal Radiol1993; 22: 173–176.
37.
SilvaDBDPianovskiMADCostaMTFD.Childhood and adolescent cancer: early diagnosis challenges. Rev Assoc Med Bras2024; 70: e2024S128.
38.
MullenCJRBarrRDFrancoEL.Timeliness of diagnosis and treatment: the challenge of childhood cancers. Br J Cancer2021; 125: 1612–1620.
39.
UzunovaLBailieHMurrayMJ.Fifteen-minute consultation: a general paediatrician’s guide to oncological abdominal masses. Arch Dis Child2019; 104: 129–134.
40.
ThorbinsonCCaltonEBrennanB.An approach to oncological abdominal masses in children. Paediatr Child Health2021; 31: 295–299.
41.
NealRTharmanathanPFranceB, et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer2015; 112: S92–S107.
42.
ShanmugavadivelDLiuJFRitzmannTA, et al. Quantifying diagnostic intervals and routes to diagnosis for children and young people with cancer in the UK (Childhood Cancer Diagnosis study, CCD): a population-based observational study. Lancet Reg Health Eur2025; 38: 10098.
43.
HallidayKDrinkwaterKHowlettDC.Evaluation of paediatric radiology services in hospitals in the UK. Clin Radiol2016; 71: 1263–1267.
44.
National Imaging Board. Interventional Radiology: Guidance for Service Delivery. London: Department of Health, 2010.
45.
NaukaPCGalenBT.The focused assessment with sonography in cancer (FASC) examination. POCUS J2020; 5: 42–45.
46.
JamjoomRSEtoomYSolanoT, et al. Emergency point-of-care ultrasound detection of cancer in the pediatric emergency department. Pediatr Emerg Care2015; 31: 602–604.
47.
McCrearyDJLashhabS.A rare cause of neck lump in an infant. POCUS J2022; 7: 220–224.
48.
Di SerafinoMIacobellisFSchilliròML, et al. Common and uncommon errors in emergency ultrasound. Diagnostics2022; 12: 631.
49.
WuWTChangKVHsuYC, et al. Artifacts in musculoskeletal ultrasonography: from physics to clinics. Diagnostics2020; 10: 645.
50.
GriffithJFYipSWYHungEHY, et al. Accuracy of ultrasound in the characterisation of deep soft tissue masses: a prospective study. Eur Radiol2020; 30: 5894–5903.
51.
BianchiS.Ultrasound and bone: a pictorial review. J Ultrasound2020; 23: 227–257.
52.
CharnockM.Soft-tissue sarcoma masquerading as a haematoma. J Med Ultrasound2019; 27: 50–53.
